0001209191-13-001563.txt : 20130103
0001209191-13-001563.hdr.sgml : 20130103
20130103185017
ACCESSION NUMBER: 0001209191-13-001563
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121231
FILED AS OF DATE: 20130103
DATE AS OF CHANGE: 20130103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Somaxon Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001339455
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200161599
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10935 VISTA SORRENTO PARKWAY
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 876-6500
MAIL ADDRESS:
STREET 1: 10935 VISTA SORRENTO PARKWAY
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAST ERLE T
CENTRAL INDEX KEY: 0001051411
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51665
FILM NUMBER: 13509049
MAIL ADDRESS:
STREET 1: C/O SPIROS DEVELOPMENT CORP II INC
STREET 2: 7475 LUSK BLVD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2012-12-31
0
0001339455
Somaxon Pharmaceuticals, Inc.
SOMX
0001051411
MAST ERLE T
C/O SOMAXON PHARMACEUTICALS, INC.
440 STEVENS AVENUE, SUITE 200
SOLANA BEACH
CA
92075
1
0
0
0
Common Stock
2012-12-31
4
A
0
7820
0.00
A
34781
D
Pursuant to the Director Compensation Policy, these RSUs were granted in lieu of cash board fees and retainers. Subject to the terms of the Restricted Stock Unit Agreement, 100% of the RSU Award shall vest upon the earlier of (a) the time that is immediately prior to the consummation of the merger contemplated by the Agreement and Plan of Merger by and among the Company, Pernix Therapeutics Holdings, Inc. and Pernix Acquisition Corp. I dated as of December 10, 2012 (the "Merger Agreement"), or (b) the first date included within an open trading window under the Company's Insider Trading Policy following any termination of the Merger Agreement, subject in either case to Participant's continued status as an Employee, Independent Director or Consultant (each as defined in the Plan) of the Company or any Subsidiary on such vesting date.
/s/ Matthew W. Onaitis, Attorney-in-fact
2013-01-03